Your browser doesn't support javascript.
loading
EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy.
Stoddart, Angela; Fernald, Anthony A; Davis, Elizabeth M; McNerney, Megan E; Le Beau, Michelle M.
Affiliation
  • Stoddart A; Department of Medicine, University of Chicago, Chicago, IL. Electronic address: astoddar@bsd.uchicago.edu.
  • Fernald AA; Department of Medicine, University of Chicago, Chicago, IL.
  • Davis EM; Department of Medicine, University of Chicago, Chicago, IL.
  • McNerney ME; Department of Pathology, University of Chicago, Chicago, IL; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL; Department of Pediatrics, University of Chicago, Chicago IL.
  • Le Beau MM; Department of Medicine, University of Chicago, Chicago, IL; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL.
Exp Hematol ; 115: 54-67, 2022 11.
Article in En | MEDLINE | ID: mdl-35995095
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cells / Haploinsufficiency Type of study: Prognostic_studies Limits: Aged / Animals / Humans Language: En Journal: Exp Hematol Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cells / Haploinsufficiency Type of study: Prognostic_studies Limits: Aged / Animals / Humans Language: En Journal: Exp Hematol Year: 2022 Type: Article